PFIZ34:BVMF
Pfizer BDR
R$36.81
arrow_downward
-0.16%(-0.060) 1D
Oct 1, 4:54:30 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$37.24
High
R$37.24
Low
R$36.70
Mkt. cap
160.27B
Avg. vol.
8.83K
Volume
2.28K
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
75K
Open
R$37.24
High
R$37.24
Low
R$36.70
Mkt. cap
160.27B
Avg. vol.
8.83K
Volume
2.28K
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
Investing.com
·
3 hours ago
Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims By Reuters
AD HOC NEWS
·
9 hours ago
Pfizer presents tilrekimig data while Pfizer stock stays near its prior close
Business Wire
·
13 hours ago
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
Trefis
·
1 day ago
Are You Overpaying For Pfizer Stock Versus Its Rivals?
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com